Full View

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer

J Tie, JD Cohen, K Lahouel, SN Lo… - … England Journal of …, 2022 - Mass Medical Soc
Background The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …
被引用次数：509 相关文章

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

DYNAMIC Investigators - New England Journal of …, 2022 - pure.johnshopkins.edu
BACKGROUND The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.

J Tie, JD Cohen, K Lahouel, SN Lo, Y Wang… - The New England …, 2022 - europepmc.org
Background The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …
[PDF] viamedica.pl

[PDF][PDF] Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer

J Tie, J Cohen, M Phil - Lancet, 2022 - journals.viamedica.pl
Metody. Badanie przeprowadzono, aby ocenić, czy uzależnienie sposobu postępowania od
obecności ctDNA może ograniczyć zastosowanie uzupełniającej chemioterapii bez …

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

J Tie, JD Cohen, K Lahouel, SN Lo, Y Wang… - 2022 - swhealthcare.intersearch.com.au
BACKGROUND: The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …
[PDF] continew-medical.com.tw

[PDF][PDF] Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

J Tie, JD Cohen, K Lahouel, SN Lo, Y Wang… - N Engl J …, 2022 - continew-medical.com.tw
BACKGROUND The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer

J Tie, JD Cohen, K Lahouel, SN Lo, Y Wang… - 2022 - ro.ecu.edu.au
BACKGROUND The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

J Tie, JD Cohen, K Lahouel, SN Lo… - The New England …, 2022 - research.monash.edu
BACKGROUND The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …
[HTML] nih.gov

[HTML][HTML] Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

J Tie, JD Cohen, K Lahouel, SN Lo… - The New England …, 2022 - ncbi.nlm.nih.gov
BACKGROUND The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …

[引用][C] Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

J Tie, JD Cohen, K Lahouel, SN Lo… - … England Journal of …, 2022 - espace.library.uq.edu.au
BACKGROUND The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …